News

The full-year tariff impact of 85 cents per share would have more than doubled without mitigation actions underway, ...
The partnership extends the compatibility of Sequel’s Twiist system to allow people with Type 1 diabetes to pair the device ...
Omniasecure, which was authorized for placement in the heart’s right ventricle, is the world’s smallest defibrillation lead, ...
In a letter to the FTC, three Democratic senators called for privacy standards for brain computer interface technology.
Boston Scientific, Medtronic, Abbott and J&J unveiled new data for their PFA devices in tandem with the Heart Rhythm ...
Inspectors found ICU Medical made multiple changes to infusion pumps without submitting premarket notifications.
McEvoy, the former leader of Johnson & Johnson’s medtech business, started immediately. Jim Hollingshead, who was CEO of ...
William Blair analyst Brandon Vazquez said 2025 could be the first year market leader Intuitive Surgical will face meaningful ...
While J&J, Abbott and Boston Scientific have all said the White House’s tariff policies will cost them hundreds of millions ...
Jon Monson, currently Boston Scientific's senior vice president for investor relations, will replace Brennan beginning June ...
Former Avanos Medical executive Michael Greiner has left the company. Greiner was CFO and chief transformation officer at the ...